Lu S, Zhang H, Wei X, et al. Diabetes Metab Syndr Obes. 2019;12:1355–1363.
The authors have advised on page 1360 is incorrect. Due to an error at the time of figure assembly NC and H in the TLR4-/-groups row were duplicated. The correct is shown below.
Figure 7 Effect of DMDD on the ultrastructural changes in the renal tissue of WT and KO mice. NC: normal control, DN: diabetic nephropathy group, G: gliquidone group (10 mg.kg−1.d−1), H: high dosage of DMDD group (50 mg.kg−1.d−1), M: medium dosage of DMDD group (25 mg.kg−1.d−1), L: low dosage of DMDD group (12.5 mg.kg−1.d−1).
Abbreviations: DMDD, 2- dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione; WT, wild type; KO, knockout.
![Figure 7 Effect of DMDD on the ultrastructural changes in the renal tissue of WT and KO mice. NC: normal control, DN: diabetic nephropathy group, G: gliquidone group (10 mg.kg−1.d−1), H: high dosage of DMDD group (50 mg.kg−1.d−1), M: medium dosage of DMDD group (25 mg.kg−1.d−1), L: low dosage of DMDD group (12.5 mg.kg−1.d−1).Abbreviations: DMDD, 2- dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione; WT, wild type; KO, knockout.](/cms/asset/4f612b4f-6b24-4cb3-b882-fe5945927cb5/dmso_a_12172486_f0001_b.jpg)
The authors apologize for this error and advise it does not affect the results of the paper.